Artemis Strategic Investment Corp
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | |
|---|---|---|
| Revenue | — | — |
| Operating income | $5.8M | −$282,666 |
| Net income | $3.7M | $312,118 |
| Total assets | $208.5M | $206.7M |
| Total liabilities | $8.9M | $16.9M |
| Equity | −$12.6M | $0 |
| EPS (diluted) | — | — |
| Shares out. | — | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- —
- Return on equity
- −29.0%
- Return on assets
- 1.8%
- Return on capital (ROCE)
- 2.9%
- Liabilities / assets
- 4.3%
- Debt / equity
- —
- Book value / share
- —
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- 1071.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -1.61distress
- Accruals / assets
- 2.2%clean
- Piotroski F-Score
- 3/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Other material eventOct 30, 2023
- Regulation FD disclosureSep 19, 2023
- Delisting / listing-standard noticeSep 14, 2023
- Entered a material agreementSep 8, 2023
- Entered a material agreementAug 11, 2023
- Other material eventAug 7, 2023
- Director / officer changeAug 4, 2023
- Entered a material agreement · Amended charter or bylaws · Shareholder vote · Other material eventJul 6, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SEC STAFF ACTIONJul 24, 2024
- SC 13G/AFeb 14, 2024
- SC 13G/AFeb 14, 2024
- SC 13G/AARTEMIS STRATEGIC INVESTMENT CORP 13GAFeb 9, 2024
- 15-12GNov 13, 2023
- 25-NSENov 3, 2023
- 8-K/AFORM 8-K/ANov 2, 2023
- 8-KFORM 8-KOct 30, 2023
- 425Sep 19, 2023
- 8-KFORM 8-KSep 19, 2023
- 8-KFORM 8-KSep 14, 2023
- S-4FORM S-4Sep 8, 2023
- 425Sep 8, 2023
- 8-KFORM 8-KSep 8, 2023
- 425Aug 11, 2023